NGNE
Neurogene Inc
28.30$
-9.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 89.2% | 90.0% | 89.1% | 88.5% | 87.5% | 94.1% | 94.0% | 93.8% | 94.0% | 93.9% | 93.8% | 93.7% | |
| 28.2% | 66.6% | 76.9% | 61.7% | 40.6% | 40.7% | 22.4% | 19.8% | 24.7% | 35.9% | 47.2% | 46.0% | |
| 87.6% | 88.6% | 86.8% | 85.6% | 84.7% | 93.1% | 92.8% | 92.3% | 92.2% | 93.0% | 92.4% | 92.2% | |
| – | 0.3% | 0.3% | 0.4% | 0.4% | 0.2% | 0.2% | 0.4% | 0.3% | 0.2% | – | – | |
| 16.0% | 16.4% | 12.6% | 13.8% | 16.3% | 7.6% | 7.5% | 8.1% | 7.7% | 8.4% | 9.6% | 11.1% | |
| 5.8% | 10.3% | 6.0% | 7.3% | 9.6% | 4.5% | 4.5% | 5.2% | 5.1% | 5.7% | 7.2% | 8.8% | |
| 2.6% | 1.3% | 1.4% | 1.6% | 2.2% | 0.9% | 1.3% | 1.4% | 1.3% | 1.1% | 1.2% | 1.2% | |
| 2.4% | 1.2% | 0.8% | 1.0% | 1.0% | 0.4% | 1.0% | 0.7% | 0.5% | 0.7% | 1.8% | 1.3% | |
| 84.0% | 83.6% | 87.4% | 86.2% | 83.7% | 92.4% | 92.5% | 91.9% | 92.3% | 91.6% | 90.4% | 88.9% | |
| -526.7% | -84.1% | -104.5% | -123.8% | -147.9% | -78.1% | -90.4% | -103.2% | -113.9% | -121.9% | -145.8% | -171.1% | |
| 12.4% | 5.8% | 8.7% | 9.4% | 10.3% | 4.4% | 6.7% | 7.1% | 7.4% | 5.4% | 8.5% | 9.2% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.